Abstract
WE have hypothesized that end-to-end chromosome fusions observed in some tumours could play a part in genetic instability associated with tumorigenesis and that fusion may result from the loss of the long stretches of G-rich repeats found at the ends of all linear chromosomes1. We therefore asked whether there is telomere loss or reduction in common tumours. Here we show that in most of the colorectal carcinomas that we analysed, there is a reduction in the length of telomere repeat arrays relative to the normal colonic mucosa from the same patient. We speculate on the consequences of this loss for tumorigenesis. We also show that the telomere arrays are much smaller in colonic mucosa and blood than in fetal tissue and sperm, and that there is a reduction in average telomere length with age in blood and colon mucosa. We propose that the telomerase2–4 is inactive in somatic tissues, and that telomere length is an indicator of the number of cell divisions that it has taken to form a particular tissue and possibly to generate tumours.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
196,21 € per year
only 3,85 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hastie, N. D. & Allshire, R. C. Trends Genet. 5, 326–331 (1989).
Greider, C. W. & Blackburn, E. H. Cell 43, 405–413 (1985).
Greider, C. W. & Blackburn, E. H. Nature 337, 331–337 (1989).
Morin, G. B. Cell 59, 521–529 (1989).
Allshire, R. C. et al. Nature 332, 656–659 (1988).
Moyzis, R. K. et al. Proc. natn. Acad. Sci. U.S.A. 85, 6222–6626 (1988).
Allshire, R. C., Dempster, M. & Hastie, N. D. Nucleic Acids Res. 17, 4611–4627 (1989).
Brown, W. R. A. Nature 338, 774–776 (1989).
Cross, S. H., Allshire, R. C., McKay, S., McGill, N. & Cooke, H. J. Nature 338, 771–774 (1989).
de Lange, T. et al. Molec. cell Biol. 10, 518–527 (1990).
Cooke, H. J. & Smith, B. A. Cold Spring Harb. Symp. quant. Biol 6, 213–219 (1986).
Potten, C. S. & Morris, R. J. J. Cell Sci. Suppl. 10, 45–62 (1988).
Levis, R. W. Cell 58, 791–801 (1989).
Lundblad, V. & Szostak, J. W. Cell 57, 633–643 (1989).
McClintock, B. Genetics 26, 234–282 (1941).
Larson, D. D., Spangler, E. A. & Blackburn, E. H. Cell 50, 477–483 (1987).
McClintock, B. Cold Spring Harb. Symp. Quant. Biol. 16, 13–49 (1951).
Benn, P. A. Am. J. Hum. Genet. 28, 465–473 (1976).
Harley, C. B., Futcher, A. B. & Greider, C. W. Nature 345, 458–460 (1990).
Mandahl, N. et al. Hum. Genet. 71, 321–324 (1985).
Dewald, C. W. et al. Mayo Clin. Proc. 62, 558–567 (1987).
Kovacks, G., Muller-Brechlin, R. & Szucs, S. Cancer Genet Cytogenet 28, 363–365 (1987).
Morgan, R. et al. Hum. Genet. 73, 260–263 (1986).
Kaufman, R. J., Sharp, P. A. & Latt, S. A. Molec. cell Biol. 3, 699–711 (1983).
Vogelstein, B. et al. New Engl. J. Med. 319, 525–532 (1988).
Vogelstein, B. et al. Science 244, 207–211 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hastie, N., Dempster, M., Dunlop, M. et al. Telomere reduction in human colorectal carcinoma and with ageing. Nature 346, 866–868 (1990). https://doi.org/10.1038/346866a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/346866a0
This article is cited by
-
A CRISPR base editing approach for the functional assessment of telomere biology disorder-related genes in human health and aging
Biogerontology (2024)
-
Cellular reprogramming and epigenetic rejuvenation
Clinical Epigenetics (2021)
-
QSAR, pharmacophore modeling and molecular docking studies to identify structural alerts for some nitrogen heterocycles as dual inhibitor of telomerase reverse transcriptase and human telomeric G-quadruplex DNA
Future Journal of Pharmaceutical Sciences (2021)
-
High-throughput STELA provides a rapid test for the diagnosis of telomere biology disorders
Human Genetics (2021)
-
Leukocyte telomere length in patients with transfusion-dependent thalassemia
BMC Medical Genomics (2020)